Scotts Miracle-Gro Company (The) Common Stock (SMG)

Total Costs & Expenses

$2.96B

TTM · Period ending: · USD

SMG logo

SMG Total Costs & Expenses

Latest reported$2.96B
SMG TTM Total Costs & Expenses ($325.80M → $2.96B)
High-resolution chart · PNG

SMG total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Scotts Miracle-Gro Company (The) Common Stock Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
2,958,600,000
2,929,100,000
2,957,200,000
3,054,600,000
3,147,900,000
3,177,000,000
3,354,000,000
3,343,900,000
3,503,700,000
3,543,000,000
3,615,000,000
3,725,700,000
3,652,700,000
4,359,900,000
4,325,100,000
4,358,100,000
4,415,500,000
3,974,500,000
4,088,700,000
4,201,900,000
4,307,600,000
4,208,200,000
3,832,600,000
3,546,400,000
3,214,300,000
2,919,400,000
2,789,800,000
2,741,300,000
2,674,400,000
2,552,600,000
2,423,900,000
2,339,700,000
2,261,100,000
2,304,400,000
2,432,500,000
2,458,500,000
2,489,000,000
2,442,800,000
2,468,400,000
2,489,300,000
2,543,800,000
2,714,600,000
2,678,800,000
2,650,000,000
2,630,700,000
2,553,400,000
2,524,100,000
2,496,900,000
2,480,400,000
2,494,100,000
2,482,600,000
2,495,200,000
2,488,800,000
2,490,000,000
2,593,100,000
2,602,700,000
2,623,200,000
2,582,900,000
2,513,400,000
2,529,300,000
2,564,700,000
2,656,400,000
2,690,600,000
2,734,000,000
2,865,000,000
2,947,800,000
2,849,800,000
2,872,500,000
2,823,700,000
2,870,000,000
2,896,100,000
2,883,800,000
2,837,800,000
2,631,600,000
2,614,600,000
2,591,900,000
2,606,700,000
2,553,000,000
2,469,700,000
2,440,000,000
2,324,300,000
2,265,300,000
2,160,900,000
2,169,100,000
2,070,900,000
1,908,400,000
1,865,300,000
1,774,700,000
1,758,600,000
1,709,100,000
1,666,000,000
1,651,200,000
1,631,200,000
1,600,900,000
1,522,300,000
1,511,400,000
1,464,400,000
1,455,300,000
1,566,000,000
1,561,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.